136 results on '"Fyles, Anthony W"'
Search Results
2. Figure S2 from An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
3. Supplementary Data 1 from An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
4. Data from An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
5. An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
6. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
7. Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer
8. Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis
9. Adjuvant Chemotherapy Following Chemo-Radiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemo-Radiation Alone: The Randomised Phase 3 OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)
10. TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer
11. LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC).
12. Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
13. Applications to Gynecological Cancers
14. The Significance of Tumoral ERCC1 Status in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiation Therapy: A Multicenter Clinicopathologic Analysis
15. Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ
16. Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).
17. High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone
18. Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX
19. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
20. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation
21. Applications to Gynecological Cancers
22. Estimating hypoxic status in human tumors: A simulation using Eppendorf oxygen probe data in cervical cancer patients
23. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy
24. Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer
25. Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation
26. Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension
27. Interrelationship of proliferation and hypoxia in carcinoma of the cervix
28. The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis
29. Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer.
30. Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer.
31. CCTG EN10: A phase II study of tailored adjuvant therapy in POLE -mutated and p53-wildtype/NSMP early-stage endometrial cancer (EC)—RAINBO BLUE and TAPER.
32. Final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.
33. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes
34. Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy
35. Adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer: Toxicity and quality-of-life results of the randomized PORTEC-3 trial.
36. The role of PET-CT in treatment decision making for women with locally advanced cervical cancer.
37. Analysis of outcomes in patients (pts) with recurrent ovarian clear cell carcinoma (ROCCC): Time to rethink our approach to treatment.
38. Development and implementation of communities of practice at Cancer Care Ontario (CCO).
39. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation
40. Abstract 2059: The role of microRNA-196b in cervical cancer
41. Follow-up for women after treatment for cervical cancer: A systematic review
42. Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.
43. Uterine Cervix Cancer
44. Applications to Gynecological Cancers.
45. Anemia, hypoxia and transfusion in patients with cervix cancer: a review
46. Proliferation parameters in epidermoid carcinomas of the anal canal
47. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables
48. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome
49. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis
50. Cervix cancer oxygenation measured following external radiation therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.